Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study

Introduction: Toxic epidermal necrolysis and Stevens–Johnson syndrome are acute life-threatening mucocutaneous reactions to drugs. The aims of the study were to identify these drugs and characterize population prone to these reactions. Materials and Methods: Data including demographics, culprit d...

Full description

Bibliographic Details
Main Authors: Ewa Stocka-Łabno, Natalia Gabzdyl, Magdalena Misiak-Galazka, Małgorzata Pawłowska-Kisiel, Tomasz Łazowski, Lidia Rudnicka
Format: Article
Language:English
Published: Our Dermatology Online 2016-10-01
Series:Nasza Dermatologia Online
Subjects:
Online Access:http://www.odermatol.com/issue-in-html/2016-4-2/
_version_ 1818237118409867264
author Ewa Stocka-Łabno
Natalia Gabzdyl
Magdalena Misiak-Galazka
Małgorzata Pawłowska-Kisiel
Tomasz Łazowski
Lidia Rudnicka
author_facet Ewa Stocka-Łabno
Natalia Gabzdyl
Magdalena Misiak-Galazka
Małgorzata Pawłowska-Kisiel
Tomasz Łazowski
Lidia Rudnicka
author_sort Ewa Stocka-Łabno
collection DOAJ
description Introduction: Toxic epidermal necrolysis and Stevens–Johnson syndrome are acute life-threatening mucocutaneous reactions to drugs. The aims of the study were to identify these drugs and characterize population prone to these reactions. Materials and Methods: Data including demographics, culprit drug, clinical characteristics, course of disease, treatment given, and therapeutic responses were retrospectively collected from medical records of 31 patients admitted to Department of Dermatology from January 2009 to December 2014. Results: Drugs most commonly involved in Stevens–Johnson syndrome were antimicrobials: ciprofloxacin, doxycycline, cefuroxime, trimethoprim, amoxicillin, clindamycin, co-trimoxazole (50% of patients) and nonsteroidal anti-inflammatory drugs: ibuprofen, naproxen, metamizole, piroxicam (29% of patients). Drugs involved in toxic epidermal necrolysis were antimicrobials: sulfasalazine, co-trimoxazole, cefuroxime, clindamycin (71% of patients) and anticonvulsants: lamotrigine (29% of patients). The comorbidities’ characteristic for the group of patients affected by toxic epidermal necrolysis were psychiatric and autoimmune disorders. The most common complication was infection. Two patients died and in both cases the cause of death was sepsis. Conclusion: The study indicates that in observed population drugs with the highest risk of most severe reactions are lamotrigine (anticonvulsant) and antimicrobials (most commonly sulfonamides), therefore it is advisable to consider carefully administration of these drugs, especially to patients with history of autoimmune reactions.
first_indexed 2024-12-12T12:20:40Z
format Article
id doaj.art-9d68aa69560749d3a49923c771be5811
institution Directory Open Access Journal
issn 2081-9390
language English
last_indexed 2024-12-12T12:20:40Z
publishDate 2016-10-01
publisher Our Dermatology Online
record_format Article
series Nasza Dermatologia Online
spelling doaj.art-9d68aa69560749d3a49923c771be58112022-12-22T00:24:41ZengOur Dermatology OnlineNasza Dermatologia Online2081-93902016-10-017438138410.7241/ourd.20164.104Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective studyEwa Stocka-Łabno0Natalia Gabzdyl1Magdalena Misiak-Galazka2Małgorzata Pawłowska-Kisiel3Tomasz Łazowski4Lidia Rudnicka51Department of Dermatology, Medical University of Warsaw, Warsaw, Poland1Department of Dermatology, Medical University of Warsaw, Warsaw, Poland1Department of Dermatology, Medical University of Warsaw, Warsaw, Poland1Department of Dermatology, Medical University of Warsaw, Warsaw, Poland2Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland1Department of Dermatology, Medical University of Warsaw, Warsaw, PolandIntroduction: Toxic epidermal necrolysis and Stevens–Johnson syndrome are acute life-threatening mucocutaneous reactions to drugs. The aims of the study were to identify these drugs and characterize population prone to these reactions. Materials and Methods: Data including demographics, culprit drug, clinical characteristics, course of disease, treatment given, and therapeutic responses were retrospectively collected from medical records of 31 patients admitted to Department of Dermatology from January 2009 to December 2014. Results: Drugs most commonly involved in Stevens–Johnson syndrome were antimicrobials: ciprofloxacin, doxycycline, cefuroxime, trimethoprim, amoxicillin, clindamycin, co-trimoxazole (50% of patients) and nonsteroidal anti-inflammatory drugs: ibuprofen, naproxen, metamizole, piroxicam (29% of patients). Drugs involved in toxic epidermal necrolysis were antimicrobials: sulfasalazine, co-trimoxazole, cefuroxime, clindamycin (71% of patients) and anticonvulsants: lamotrigine (29% of patients). The comorbidities’ characteristic for the group of patients affected by toxic epidermal necrolysis were psychiatric and autoimmune disorders. The most common complication was infection. Two patients died and in both cases the cause of death was sepsis. Conclusion: The study indicates that in observed population drugs with the highest risk of most severe reactions are lamotrigine (anticonvulsant) and antimicrobials (most commonly sulfonamides), therefore it is advisable to consider carefully administration of these drugs, especially to patients with history of autoimmune reactions.http://www.odermatol.com/issue-in-html/2016-4-2/Stevens-Johnson syndrome; Toxic epidermal necrolysis; Adverse drug reaction
spellingShingle Ewa Stocka-Łabno
Natalia Gabzdyl
Magdalena Misiak-Galazka
Małgorzata Pawłowska-Kisiel
Tomasz Łazowski
Lidia Rudnicka
Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study
Nasza Dermatologia Online
Stevens-Johnson syndrome; Toxic epidermal necrolysis; Adverse drug reaction
title Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study
title_full Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study
title_fullStr Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study
title_full_unstemmed Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study
title_short Stevens–Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study
title_sort stevens johnson syndrome and toxic epidermal necrolysis in an academic hospital setting a 5 year retrospective study
topic Stevens-Johnson syndrome; Toxic epidermal necrolysis; Adverse drug reaction
url http://www.odermatol.com/issue-in-html/2016-4-2/
work_keys_str_mv AT ewastockałabno stevensjohnsonsyndromeandtoxicepidermalnecrolysisinanacademichospitalsettinga5yearretrospectivestudy
AT nataliagabzdyl stevensjohnsonsyndromeandtoxicepidermalnecrolysisinanacademichospitalsettinga5yearretrospectivestudy
AT magdalenamisiakgalazka stevensjohnsonsyndromeandtoxicepidermalnecrolysisinanacademichospitalsettinga5yearretrospectivestudy
AT małgorzatapawłowskakisiel stevensjohnsonsyndromeandtoxicepidermalnecrolysisinanacademichospitalsettinga5yearretrospectivestudy
AT tomaszłazowski stevensjohnsonsyndromeandtoxicepidermalnecrolysisinanacademichospitalsettinga5yearretrospectivestudy
AT lidiarudnicka stevensjohnsonsyndromeandtoxicepidermalnecrolysisinanacademichospitalsettinga5yearretrospectivestudy